Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cyclosporine vs Tears in Multifocal IOL Implantation
NCT00349583Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Countries
- 1
01
Overview
A Phase 4 trial of CyclAGel in dry eye syndrome (DED), sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
CyclAGel
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00349583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349583.